| | Business Summary | | Enzo
Biochem,
Inc.
is
engaged
in
research,
development,
manufacturing
and
marketing
of
diagnostic
and
research
products
based
on
genetic
engineering,
biotechnology
and
molecular
biology.
These
products
are
designed
for
the
diagnosis
of
and/or
screening
for
infectious
diseases,
cancers,
genetic
defects
and
other
medically
pertinent
diagnostic
information.
The
Company
is
conducting
research
and
development
activities
in
the
development
of
therapeutic
products
based
on
its
technology
platform
of
genetic
modulation
and
immune
modulation.
The
Company
also
operates
a
clinical
reference
laboratory
that
offers
and
provides
diagnostic
medical
testing
services
to
the
health
care
community.
The
business
activities
of
the
Company
are
performed
by
its
three
wholly
owned
subsidiaries,
Enzo
Diagnostics,
Inc.,
Enzo
Therapeutics,
Inc.,
and
Enzo
Clinical
Labs,
Inc. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | ENZ
develops,
manufactures
and
markets
health
care
products
based
on
molecular
biology
and
genetic
engineering
techniques,
and
provides
medical
diagnostic
services
to
the
medical
community.
For
the
nine
months
ended
4/30/01,
total
revenues
rose
20%
to
$42.9
million.
Net
income
rose
1%
to
$5.1
million.
Revenues
reflect
increased
income
from
clinical
reference
laboratory
operation
and
higher
research
products
sales.
Earnings
were
partially
offset
by
increased
R&D
expenses. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Elazar Rabbani, Ph.D., 56
CEO,
Chairman | $496K | -- | Barry Weiner, 50
Pres | 440K | $931K | Shahram Rabbani, 48
COO,
Sec., Treasurer | 440K | -- | Dean Engelhardt, Ph.D., 60
Exec.
VP | 216K | 620K | Norman Kelker, Ph.D., 61
Sr.
VP | -- | -- | | Dollar
amounts are as of 31-July-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/e/enz.gif)